Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386:896–912. https://doi.org/10.1016/S0140-6736(14)61393-3.

Article  PubMed  CAS  Google Scholar 

Schiess N, Cataldi R, Okun MS, et al. Six action steps to address global disparities in Parkinson disease: a World Health Organization priority. JAMA Neurol. 2022;79:929–36. https://doi.org/10.1001/jamaneurol.2022.1783.

Article  PubMed  Google Scholar 

Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018;8(s1):S3–8. https://doi.org/10.3233/JPD-181474.

Article  PubMed  PubMed Central  Google Scholar 

Reeve A, Simcox E, Turnbull D. Ageing and Parkinson’s disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14:19–30. https://doi.org/10.1016/j.arr.2014.01.004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014;29:1583–90. https://doi.org/10.1002/mds.25945.

Article  PubMed  Google Scholar 

Hirsch L, Jette N, Frolkis A, et al. The incidence of Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46:292–300. https://doi.org/10.1159/000445751.

Article  PubMed  Google Scholar 

Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257–72. https://doi.org/10.1016/S1474-4422(16)30230-7.

Article  PubMed  Google Scholar 

van Marum RJ. Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol. 2020;86:2014–6. https://doi.org/10.1111/bcp.14539.

Article  PubMed  PubMed Central  Google Scholar 

Kwaśniak-Butowska M, Dulski J, Pierzchlińska A, Białecka M, Wieczorek D, Sławek J. Cardiovascular dysautonomia and cognition in Parkinson’s disease - a possible relationship. Neurol Neurochir Pol. 2021;55:525–35. https://doi.org/10.5603/PJNNS.a2021.0040.

Article  PubMed  Google Scholar 

Azevedo P, Aquino CC, Fasano A. Surgical management of Parkinson’s disease in the elderly. Mov Disord Clin Pract. 2021;8:500–9. https://doi.org/10.1002/mdc3.13161.

Article  PubMed  PubMed Central  Google Scholar 

Virameteekul S, Phokaewvarangkul O, Bhidayasiri R. Profiling the most elderly parkinson’s disease patients: does age or disease duration matter? PLoS ONE. 2021;16: e0261302. https://doi.org/10.1371/journal.pone.0261302.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vaswani PA, Tropea TF, Dahodwala N. Overcoming barriers to Parkinson disease trial participation: increasing diversity and novel designs for recruitment and retention. Neurotherapeutics. 2020;17:1724–35. https://doi.org/10.1007/s13311-020-00960-0.

Article  PubMed  PubMed Central  Google Scholar 

Pitkala KH, Strandberg TE. Clinical trials in older people. Age Ageing. 2022;51:afab282. https://doi.org/10.1093/ageing/afab282.

Article  PubMed  PubMed Central  Google Scholar 

Herrera AP, Snipes SA, King DW, et al. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health. 2010;100 Suppl 1(Suppl 1):S105-12. https://doi.org/10.2105/AJPH.2009.162982.

Article  PubMed  Google Scholar 

Forsat ND, Palmowski A, Palmowski Y, et al. Recruitment and retention of older people in clinical research: a systematic literature review. J Am Geriatr Soc. 2020;68:2955–63. https://doi.org/10.1111/jgs.16875.

Article  PubMed  Google Scholar 

Tse T, Fain KM, Zarin DA. How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider. BMJ. 2018;361:k1452. https://doi.org/10.1136/bmj.k1452.

Article  PubMed  PubMed Central  Google Scholar 

Helfand BKI, Webb M, Gartaganis SL, et al. The exclusion of older persons from vaccine and treatment trials for coronavirus disease 2019-missing the target. JAMA Intern Med. 2020;180:1546–9. https://doi.org/10.1001/jamainternmed.2020.5084.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Duma N, Kothadia SM, Azam TU, et al. Characterization of comorbidities limiting the recruitment of patients in early phase clinical trials. Oncologist. 2019;24:96–102. https://doi.org/10.1634/theoncologist.2017-0687.

Article  PubMed  Google Scholar 

Bourgeois FT, Orenstein L, Ballakur S, et al. Exclusion of elderly people from randomized clinical trials of drugs for ischemic heart disease. J Am Geriatr Soc. 2017;65:2354–61. https://doi.org/10.1111/jgs.14833.

Article  PubMed  PubMed Central  Google Scholar 

International Parkinson and Movement Disorder Sociaty. Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Available at: https://www.movementdisorders.org/MDS/MDS-Rating-Scales/MDS-Unified-Parkinsons-Disease-Rating-Scale-MDS-UPDRS.htm Accessed February 1, 2023

Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasquín B, et al. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc. 2013;61:734–8. https://doi.org/10.1111/jgs.12215.

Article  PubMed  Google Scholar 

Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383–9. https://doi.org/10.1200/JCO.2003.08.010.

Article  PubMed  Google Scholar 

Hamaker ME, Stauder R, van Munster BC. Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist. 2014;19:1069–75. https://doi.org/10.1634/theoncologist.2014-0093.

Article  PubMed  PubMed Central  Google Scholar 

Krysa K, Kowalczyk E, Borysowski J, et al. Exclusion of older adults from clinical trials in cancer-related pain. Front Med (Lausanne). 2022;9: 945481. https://doi.org/10.3389/fmed.2022.945481.

Article  PubMed  Google Scholar 

Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69:640–9. https://doi.org/10.1093/gerona/glt162.

Article  PubMed  Google Scholar 

Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM. Parkinson’s Foundation P4 Group. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis. 2018;4:21. https://doi.org/10.1038/s41531-018-0058-0.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Caplan Z. 2020 Census: 1 in 6 People in the United States Were 65 and Over. Washington: United States Census Bureau; https://www.census.gov/library/stories/2023/05/2020-census-united-states-older-population-grew.html Accessed July 10, 2023

Food and Drug Administration. General considerations for the clinical evaluation of drugs. Guidance for Industry. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-considerations-clinical-evaluation-drugs Accessed January 26, 2023

Food and Drug Administration. Study of drugs likely to be used in the elderly. Guidance for Industry. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/study-drugs-likely-be-used-elderly Accessed January 26, 2023

Food and Drug Administration. Evaluating inclusion and exclusion criteria in clinical trials. Workshop report. The National Press Club, Washington DC, April 16, 2018. Food and Drug Administration. Available at: https://www.fda.gov/media/134754/download Accessed January 26, 2023

European Medicines Agency. Medicines for older people. Available at: https://www.ema.europa.eu/en/human-regulatory/research-development/medicines-older-people Accessed February 6, 2023.

National Institutes of Health. Inclusion across the lifespan. Available at: https://grants.nih.gov/policy/inclusion/lifespan.htm Accessed January 27, 2023

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32014R0536 Accessed January 27, 2023

Fitzsimmons PR, Blayney S, Mina-Corkill S, Scott GO. Older participants are frequently excluded from Parkinson’s disease research. Parkinsonism Relat Disord. 2012;18:585–9. https://doi.org/10.1016/j.parkreldis.2012.03.003.

Article  PubMed  CAS  Google Scholar 

Rajapakse A, Rajapakse S, Playfer J. Age bias in clinical trials of Parkinson’s disease